0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Lentiviral Vectors and Gene Therapy (Paperback, 2012 ed.) Loot Price: R1,417
Discovery Miles 14 170
Lentiviral Vectors and Gene Therapy (Paperback, 2012 ed.): David Escors, Karine Breckpot, Frederick Arce, Grazyna Kochan, Holly...

Lentiviral Vectors and Gene Therapy (Paperback, 2012 ed.)

David Escors, Karine Breckpot, Frederick Arce, Grazyna Kochan, Holly Stephenson

Series: SpringerBriefs in Biochemistry and Molecular Biology

 (sign in to rate)
Loot Price R1,417 Discovery Miles 14 170 | Repayment Terms: R133 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Gene therapy was conceived during the early and mid part of the 20th century. At first, it was considered a revolutionary biomedical procedure, which could potentially cure any disease for which the molecular bases were understood. Since then, gene therapy has gone through many stages and has evolved from a nearly unrealistic perspective to a real life application. Clinical efficacy in humans was demonstrated at the beginning of this century after its successful application in small-scale clinical trials to cure severe immunodeficiency in children. However, their successes were overshadowed some time later by the occurrence of vector-related leukaemia in a number of treated children. It is in this context that lentiviral vectors have appeared, with improved efficiency and, possibly, increased biosafety. Very recently, the first clinical trials with lentivectors have been carried out with some success.

This Brief firstly defines gene therapy, and places lentivectors within this fascinating therapeutic strategy. Then follows a comprehensive description of the development of retroviral and lentiviral vectors and how to specifically target distinct cell types and tissues. The authors also discuss the application of lentivector gene therapy for the treatment of cancer and autoimmune diseases, ending with the application of lentivectors in human gene therapy clinical trials.

General

Imprint: Springer Basel
Country of origin: Switzerland
Series: SpringerBriefs in Biochemistry and Molecular Biology
Release date: March 2012
First published: 2012
Authors: David Escors • Karine Breckpot • Frederick Arce • Grazyna Kochan • Holly Stephenson
Dimensions: 235 x 155 x 5mm (L x W x T)
Format: Paperback
Pages: 104
Edition: 2012 ed.
ISBN-13: 978-3-03-480401-1
Categories: Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
Books > Professional & Technical > Biochemical engineering > Biotechnology > Genetic engineering
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 3-03-480401-6
Barcode: 9783034804011

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners